Copenhagen - Delayed Quote DKK

Novo Nordisk A/S (NOVO-B.CO)

Compare
807.20 -9.40 (-1.15%)
At close: October 18 at 4:59 PM GMT+2

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

23.1

40th percentile
Medium

Environmental Risk Score

1.9

Social Risk Score

13.9

Governance Risk Score

7.3

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
8AP.DU AGIOS PHARMACEUT. DL-,001 24 -- -- --
25K.DU KARYOPHARM THERAP.DL-0001 24 -- -- --
NOVO-B.CO Novo Nordisk B A/S 24 2 13 8
1JK.SG Apellis Pharmaceuticals Inc. 24 -- -- --
LGDN.F LIGAND PHARMAC.NEW DL-001 24 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 9/2023
NOVO-B.CO
Category Average
3 Significant Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values Yes
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers